Learn from OCT’s clinical trial experts and industry opinion leaders through its library
Phase III Erectile Dysfunction Clinical Study for Futura MedicalCase
OCT, Eastern Europe’s leading CRO, partners with UK-based Futura Medical completes clinical trial enrollment of 700 patients for MED2002, a topical gel developed to treat erectile dysfunction.
Rituximab biosimilar as first-line treatment for diffuse large B-cell lymphomaCase
A portfolio project for mAbxience, where OCT Clinical Trials was responsible for all activities in Russia. Rituximab biosimilar as first-line treatment for diffuse large B-cell lymphoma.
Bioequivalence study of a drug for HIV patientsCase
An open-label, randomize, two-period, crossover study in healthy volunteers. Over 90% of volunteers were enrolled during the first two weeks. The target enrollment rates were reached within 21 days
* - Required fields